Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy
Cancer Immunology, Immunotherapy · 2025
DOI: 10.1007/s00262-025-04083-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Xia Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, People's Republic of Chin…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Chemokine CXCL13, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial Natural Science Foundation, the Postdoctoral Fellowship Program (Grade C)of China Postdoctoral Science Foundation, Henan Provincial Medical Science and Technology Research Joint Construction Project.
Abstract (Originalsprache)
Concurrent chemoradiotherapy (CCRT) is the standard treatment for advanced cervical cancer, but tumor recurrence within 3–5 years remains a significant challenge. In this study, using 10 × single-cell sequencing, we constructed a cellular atlas of the tumor microenvironment from six CSCC patients, including three with recurrence and three without, prior to CCRT. We analyzed cellular subsets, focusing on T cells, myeloid cells and cancer associated fibroblasts (CAFs), and their interactions within the tumor. Key findings revealed that CXCL13 + T cell subsets were significantly increased in non-recurrent tumors and acted as major signal senders. In recurrent tumors, FOXP3 + and IL2RA + Tregs were the primary mediators of cell communications. CXCL13 + CD8 + T cells interacted with SPP1 + tumor-associated macrophages (TAMs) in non-recurrent tumors, while in recurrent tumors, they interacted with CD163 + TAMs. Moreover, in recurrent tumor tissues, this subset demonstrates a preferential interaction with MMP3 + CAFs. The study also identified five genes (PDCD1, CXCL13, TOX, RGS1, and ALOX5AP) based on CXCL13 + T cell signature to construct predictive models for recurrence, with the random forest model showing the best performance. This study provides new insights into recurrence mechanisms in CSCC and suggests that increasing CXCL13 + T cells could be a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, People's Republic of China.
- Department of Gynecology and Obstetrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, People's Republic of China.
- Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, People's Republic of China. zhaoqitai845626@126.com.
Förderung
- Henan Provincial Natural Science Foundation
- the Postdoctoral Fellowship Program (Grade C)of China Postdoctoral Science Foundation
- Henan Provincial Medical Science and Technology Research Joint Construction Project
Zitieren
APA
Li, X., Cheng, Y., Ji, M., Liu, J., Zhao, Z., & Zhao, Q. (2025). Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04083-3
Vancouver
Li X, Cheng Y, Ji M, Liu J, Zhao Z, Zhao Q. Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04083-3
BibTeX
@article{Li2025,
author = {Li, Xia and Cheng, Yanmei and Ji, Mei and Liu, Junqi and Zhao, Zhao and Zhao, Qitai},
title = {Single-cell RNA sequencing analysis reveals a lack of CXCL13+ T cell subsets associated with the recurrence of cervical squamous cell carcinoma following concurrent chemoradiotherapy},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
doi = {10.1007/s00262-025-04083-3}
}
EUVIMED